Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 15/20 | 0.51 |
| ▸ | PPARD | Q03181 | 15/20 | 0.51 |
| ▸ | PPARA | Q07869 | 14/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.48 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7038239 | 0.90 | PPARD (0.60) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7044493 | 0.86 | PPARG (0.56) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7040316 | 0.83 | PPARA (0.51) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL6559339 | 0.81 | PPARG (0.50) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7041790 | 0.79 | PPARA (0.64) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7046584 | 0.79 | PPARG (0.62) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7041506 | 0.78 | PPARA (0.64) | PPARGPPARDPPARA | |
| SCHEMBL7044058 | 0.78 | PPARA (0.38) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7040885 | 0.77 | PPARG (0.65) | PPARGPPARDPPARANR1H2NR1H3 | |
| SCHEMBL7038241 | 0.75 | PPARD (0.61) | PPARGPPARDPPARANR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882029-B1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-0882029-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | claimed |
| WO-1997028137-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | claimed |
| EP-0882029-B1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-6090836-A | DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION | MERCK & CO., INC. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0882029-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997028137-A1 | HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |